Oxycodone
Half-Life (t½) PO: 3.5h · IV: 3.5h
Formula C18H21NO4
Molecular Weight 315.36 g/mol
Aliases OxyContin, Percocet (+APAP), Roxicodone Pharmacological Mechanism µ-opioid receptor agonist with some κ-opioid activity. Unlike hydrocodone, oxycodone itself is active (doesn't require CYP2D6 conversion). Oxymorphone is an active metabolite.
Half-Life & Elimination Curve (PO: 3.5h · IV: 3.5h) 100% 50% 25% 12.5% 0% 0h 0×t½ 3.5h 1×t½ 7h 2×t½ 10.5h 3×t½ 14h 4×t½ 17.5h 5×t½ 0×t½ (0h): 100% remaining (~32.1 µg/L) 1×t½ (3.5h): 50% remaining (~16 µg/L) 2×t½ (7h): 25% remaining (~8.02 µg/L) 3×t½ (10.5h): 12.5% remaining (~4.01 µg/L) 4×t½ (14h): 6.3% remaining (~2.01 µg/L) 5×t½ (17.5h): 3.1% remaining (~1 µg/L) Plasma (PO) t½ Decay (3.5h) Effect Site (ke0)
0×t½ 0h 100% (32.1 µg/L) 1×t½ 3.5h 50% (16 µg/L) 2×t½ 7h 25% (8.02 µg/L) 3×t½ 10.5h 12.5% (4.01 µg/L) 4×t½ 14h 6.3% (2.01 µg/L) 5×t½ 17.5h 3.1% (1 µg/L) Dosing Guidelines Oral (PO): Typical 13.3 mg (Range: 5–30 mg)Intravenous (IV): Typical 13.3 mg (Range: 5–30 mg)Pharmacokinetic Parameters Oral (PO): Bioavailability (F): 60% · Volume of Distribution (Vd): 200 L · Absorption (ka): 2.5 h⁻¹ (t½ka ≈ 17m) [PMID 1389934 ]Intravenous (IV): Bioavailability (F): 100% · Volume of Distribution (Vd): 200 L [PMID 1389934 ]Effect-Site Equilibration (ke0): 5.78 h⁻¹ (equilibration half-time t½ke0 ≈ 7m) [PMID 16729270 ]Receptor Binding & Occupancy Pathways It Modulates Target Organ Systems Chemical Structure & Identifiers InChIKey: BRUQQQPBMZOVGD-XFKAJCMBSA-NSMILES: CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)OReferences Directory Compounds Registry Human Biology Hub